Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00401687 · ClinicalTrials.gov registry record · Phase 4
DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function
A Phase 4 study of Ventricular Ejection Fraction, sponsored by Lantheus Medical Imaging.
- Completed
- Registry status
- Phase 4
- Development phase
- 131
- Enrollment target
- 10
- Study locations
NCT00401687 is a Phase 4 study of Ventricular Ejection Fraction that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 131 participants. The trial reports 10 study locations across 10 states.
The verdict
NCT00401687, a Phase 4 study of Ventricular Ejection Fraction, has completed, sponsored by Lantheus Medical Imaging.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 131 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this clinical research study is to demonstrate the ability of Definity® enhanced versus unenhanced cardiac ultrasound to improve the accuracy and reproducibility of left ventricular ejection fraction (EF) when compared to magnetic resonance imaging (MRI).
Conditions Studied
Interventions
- DRUG Definity® Vial for (Perflutren Lipid Microsphere) Injectable Suspension
Study Locations (10)
Arizona
- University of Arizona - Tucson
Illinois
- University of Chicago Medical Center - Chicago
Maryland
- Washington Hospital Center - Washington DC
Missouri
- Saint Lukes Mid America Heart Institute - Kansas City
Nebraska
- University of Nebraska Medical Center - Omaha
North Carolina
- Duke University Medical Center - Durham
Ohio
- Cleveland Clinic Foundation - Cleveland
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00401687
The ClinicalTrials.gov registry entry for NCT00401687 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lantheus Medical Imaging, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ventricular Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Definity® Vial for (Perflutren Lipid Microsphere) Injectable Suspension is the first listed.
NCT00401687 reports 10 study locations spanning 10 distinct geographic areas - top geographies include Arizona, Illinois, Maryland.
Frequently Asked Questions
What is clinical trial NCT00401687 about?
NCT00401687 is a clinical study titled "DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function". The purpose of this clinical research study is to demonstrate the ability of Definity® enhanced versus unenhanced cardiac ultrasound to improve the accuracy and reproducibility of left ventricular ejection fraction (EF) when compared to magnetic resonance imaging (MRI).
What is the current status of trial NCT00401687?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 131 participants. The study started on 2006-07. Estimated completion is 2008-04.
What conditions does trial NCT00401687 study?
This clinical trial studies the following conditions: Ventricular Ejection Fraction.
What interventions are being tested in trial NCT00401687?
The interventions under investigation include: Definity® Vial for (Perflutren Lipid Microsphere) Injectable Suspension (DRUG).
Who is sponsoring clinical trial NCT00401687?
This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00401687 being conducted?
This trial has 10 study locations across Arizona, Illinois, Maryland, Missouri, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.